Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Simultaneous analysis of first-line anti-tuberculosis drugs in tablets by UV spectrophotometry compared to capillary zone electrophoresis
Author: Marcellos, LF
Faria, AF
de Souza, MVN
Almeida, MR
Sabin, GP
Poppi, RJ
de Oliveira, MAL
Abstract: The development and optimization of a novel UV spectrophotometric methodology was proposed for simultaneous analysis of ethambutol (ETB), isoniazid (ISO), rifampicin (RIF) and pyrazinamide (PYR), using multivariate calibration based on the partial least squares method (PLS). The methodology was successfully applied for analysis of four-drug fixed dose combination (4-FDC) tablets used for tuberculosis treatment. A 3(4) Box-Behnken design, with triplicate in central point, was used for sample preparation in the calibration step. In the present case, nine latent variables were chosen for the model development that presented the smallest RMSECV and explain 98.76% of data variance in Y block (concentrations of ETB ISO, RIF and PYR) and 99.93% of data variance in X block (spectral data). PLS models for ETB, ISO, RIF and PYR presented RMSEP and R-2 values of 0.23 mg L-1 and 0.971; 0.14 mg L-1 and 0.731; 0.11 mg L-1 and 0.990 and 0.57 mg L-1 and 0.972, respectively. A validation step was performed based on the comparison between the UV spectrophotometric proposed methodology and capillary zone electrophoresis (CZE) in 4-FDC real samples and no significant difference was found between two methodologies at 95% of confidence level.
Subject: 4-FDC
UV spectrophotometry
Capillary electrophoresis
Country: Polónia
Editor: Versita
Citation: Central European Journal Of Chemistry. Versita, v. 10, n. 6, n. 1808, n. 1816, 2012.
Rights: fechado
Identifier DOI: 10.2478/s11532-012-0102-6
Date Issue: 2012
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000308950500009.pdf965.84 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.